Up in Smoke: Legacy Cremation’s Deception and the Families Left Behind
A legacy of adding to consumers’ grief.
In August 2013, a federal judge preliminarily approved a $23 million settlement to a class-action lawsuit filed against Merck Sharp & Dohme Corp. for allegedly falsely advertising that Vioxx had greater benefits than the generic versions when these benefits had not been established. According to the settlement terms, class members may receive a cash award of up to $75 with proof of purchase. (In re: Vioxx Products Liability Litigation, MDL No. 1657, E. D. LA.).
A legacy of adding to consumers’ grief.
Where there’s a pitch, there’s a legend.
Why you may want to walk away from this online retailer.
Fast-fashion retailer’s alleged fake discounts are just the beginning.
What you need to know about this purported money-making opportunity.